Alternatives to nPhase
nPhase is a Healthcare tool: AI-native clinical data platform for pharmaceutical sponsors, unifying end-to-end clinical research data and powering AI at scale. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Healthcare companies to nPhase
N-Power MedicineNot ratedN-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.
BiozNot ratedBioz is an AI search engine for life science experimentation, helping scientists find validated and cost-effective products.
ImmunaiNot ratedMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
CytoReasonNot ratedDevelops a computational model of the human body for drug discovery and development.
Nucleai3.0 out of 5 (1)AI-powered spatial biology platform for precision medicine and drug development.
QurisNot ratedAI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
RemepyNot ratedDigital therapeutics platform enhancing drug efficacy and safety through personalized software.
Lynx.MDNot ratedCloud platform for secure sharing and analysis of real-world health data for life sciences.
OncohostNot ratedLeveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.
Discure TechnologiesNot ratedDevelops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.
BenchlingNot ratedR&D cloud platform for life sciences, enabling scientific innovation and productivity.
Numenos4.0 out of 5 (2)AI platform for clinical trial data analysis to improve patient outcomes.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
QuantHealthNot ratedAI-powered patient-centric drug simulations to accelerate and de-risk drug development.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
H1Not ratedH1 is a healthcare data platform that connects life sciences companies with healthcare professionals.
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
Ray TherapeuticsNot ratedPioneering vision restoration therapies for severe retinal degenerations.
Code OceanNot ratedCloud-based platform for reproducible computational research in life sciences.
Showing the next 20 closest matches. See the rest on the nPhase profile.
Sponsored rows are paid and labelled. Advertise on this page

